Abikoff, H., Hechtman, L., Klein, R. G., et al (2004) Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 802–811.
American Academy of Child and Adolescent Psychiatry (1997) Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 85S–121S.
American Academy of Pediatrics (2001) Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics, 108, 1033–1044.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) . Washington, DC: APA.
Barkley, R. A. (1998) A theory of ADHD: inhibition, executive functions, self-control, and time. In Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment (ed. Barkley, R. A.), pp. 225–260. New York: Guilford Press.
Barkley, R. A., Fischer, M., Edelbrock, C., et al (1991) The adolescent outcome of hyperactive children diagnosed by research criteria–III. Mother–child interactions family conflicts and maternal psychopathology. Journal of Child Psychology and Psychiatry, 32, 233–255.
Barkley, R. A., Cook, E. H., Diamond, A., et al (2002) International consensus statement on ADHD – January 2002. Clinical Child and Family Psychology Review, 5, 89–111.
Barkley, R. A., Fischer, M., Smallish, L., et al (2004) Young adult follow-up of hyperactive children: antisocial activities and drug use. Journal of Child Psychology and Psychiatry, 45, 195–211.
Carlson, G. A. (1998) Mania and ADHD: comorbidity or confusion. Journal of Affective Disorders, 51, 177–187.
Castellanos, F. X. & Tannock, R. (2002) Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nature Reviews Neuroscience, 3, 617–628.
Coghill, D., Nigg, J., Rothenberger, A., et al (2005) Whither causal models in the neuroscience of ADHD?
Developmental Science, 8, 105–114.
Faraone, S.V. & Doyle, A. E. (2000) Genetic influence on attention deficit hyperactivity disorder. Current Psychiatry Reports, 2, 143–146.
Faraone, S.V., Biederman, J. & Milberger, S. (1995) How reliable are maternal reports of their children's psychopathology? One-year recall of psychiatric diagnoses of ADHD children. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1001–1008.
Fischer, M., Barkley, R. A., Edelbrock, C. S., et al (1990) The adolescent outcome of hyperactive children diagnosed by research criteria: II. Academic, attentional, and neuropsychological status. Journal of Consulting and Clinical Psychology, 58, 580–588.
Gottesman, I. I. & Gould, T. D. (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry, 160, 636–645.
Huss, M. & Lehmkuhl, U. (2002) Methylphenidate and substance abuse: a review of pharmacology, animal, and clinical studies. Journal of Attention Disorders, 6, S65–S71.
Jadad, A. R., Booker, L., Gauld, M., et al (1999) The treatment of attention-deficit hyperactivity disorder: an annotated bibliography and critical appraisal of published systematic reviews and metaanalyses. Canadian Journal of Psychiatry, 44, 1025–1035.
Kreppner, J. M., O'Connor, T. G. & Rutter, M. (2001) Can inattention/overactivity be an institutional deprivation syndrome?
Journal of Abnormal Child Psychology, 29, 513–528.
Kupfer, D. J., Baltimore, R. S., Berry, D. A., et al (2000) National Institutes of Health Consensus Development Conference Statement: Diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD). Journal of the American Academy of Child and Adolescent Psychiatry, 39, 182–193.
Lahey, B. B., Applegate, B., Mcburnett, K., et al (1994) DSM–IV field trials for attention deficit hyperactivity disorder in children and adolescents. American Journal of Psychiatry, 151, 1673–1685.
Milberger, S., Biederman, J., Faraone, S.V., et al (1997) Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children. American Journal of Addiction, 6, 318–329.
National Institute for Clinical Excellence (2000) Guidance on the Use of Methylphenidate (Ritalin, Equasym) for Attention Deficit/Hyperactivity Disorder (ADHD) in Childhood. London: National Institute for Clinical Excellence.
Nigg, J.T., Willcutt, E. G., Doyle, A. E., et al (2005) Causal heterogeneity in attention-deficit hyperactivity disorder: do we need neuropsychologically impaired subtypes?
Biological Psychiatry, 57, 1224–1230.
Philp, A.V., Watson, L. & Muir, R. (2002) Mental Health in Scotland: Information Soucres and Selected Highlights, Edinburgh: NHS Scotland Information and Statistics Division.
Rhodes, S. M., Coghill, D. R. & Matthews, K. (2004) Methylphenidate restores visual memory, but not working memory function in attention deficithyperkinetic disorder. Psychopharmacology, 175, 319–330.
Robins, E. & Guze, S. B. (1970) Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. American Journal of Psychiatry, 126, 983–987.
Schachar, R. & Tannock, R. (2002) Syndromes of hyperactivity and attention deficit. In Child and Adolescent Psychiatry (eds Rutter, M. & Taylor, E.), pp. 399–418. Oxford: Blackwell Science.
SCOTTISH INTERCOLLEGIATE GUIDELINES NETWORK (2001) Attention Deficit and Hyperkinetic Disorders in Children and Young People: A National Clinical Guideline. Edinburgh: Scottish Intercollegiate Guidelines Network.
Shaffer, D., Gould, M. S., Brasie, J., et al (1983) A Children's Global Assessment Scale (CGAS). Archives of General Psychiatry, 40, 1228–1231.
Solanto, M. V., Arnsten, A. F. & Castellanos, F. X. (2001) Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. NewYork: Oxford University Press.
Sonuga-Barke, E. J. (2003) The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neuroscience and Biobehavioural Reviews, 27, 593–604.
Swanson, J., Gupta, S., Guinta, D., et al (1999) Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Clinical Pharmacology & Therapeutics, 66, 295–305.
Tannock, R., Schachar, R. & Logan, C. (1995) Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children. Journal of Abnormal Child Psychology, 23, 235–266.
Taylor, E., Chadwick, O., Heptinstall, E., et al (1996) Hyperactivity and conduct problems as risk factors for adolescent development. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1213–1226.
Taylor, E., Dopfner, M., Sergeant, J., et al (2005) Clinical guidelines for hyperkinetic disorder – first upgrade. European Child and Adolescent Psychiatry, 13 (suppl.1), 17–30.
Volkow, N. D. & Swanson, J. M. (2003) Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. American Journal of Psychiatry, 160, 1909–1918.
Volkow, N. D., Wang, G.
Fowler, J. S., et al (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. Journal of Neuroscience, 21, RC121.
World Health Organization (1993) The ICD–10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: WHO.